Use of Dietary Supplements in Patients at Risk of Abortion Treated With Progesterone.

Lo.Li.Pharma

Status: Completed

Conditions: Pregnancy, High Risk

Treatments: Dietary Supplement: HA

Study type: Interventional

Funder types: Industry

Identifiers

NCT04874285

HMW-HA_ABORTION

Details and patient eligibility

About

The trial aims to investigate the effect of supplementation with hyaluronic acid, alpha-lipoic acid, magnesium, vitamin D and vitamin B6 in progesterone-treated pregnant women with risk factors for abortion.

Enrollment: 63 patients

Sex: Female

Ages: 18 to 50 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Women with risk factor for abortion (sub-chorionic hematoma during gestation or ART procedures)

Exclusion criteria

• Other pregnancy-related conditions
• Diabetes or hypertension
• Concomitant pharmacological therapies (anticoagulant or antihypertensive)
• Use of tocolytic drugs two months prior to enrollment
• Association with hypoglycemic drugs

Trial design

Primary purpose: Prevention

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: None (Open label)

---

63 participants in 2 patient groups

control group

No Intervention group

Description:

Women with risk factors for abortion, treated with progesterone

study group

Experimental group

Description:

Women with risk factors for abortion, treated with progesterone and a dietary supplement containing hyaluronic acid, alpha-lipoic acid, vitamin D and vitamin B6

Treatment:

Dietary Supplement: HA